Friday, 27 September 2013

Sri Lanka Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
An aspiring entrepreneur?

Learn about how top Silicon Valley entrepreneurs grew their businesses in our free ebook.
From our sponsors
Sri Lanka Pharmaceuticals and Healthcare Report Q4 2013
Sep 25th 2013, 00:00

Price: $ 1295  

BMI View: While Sri Lanka's negative pharmaceutical trade balance is expected to widen over the next five years, we are encouraged by the government's focus on increasing local production of medicines, both on a national level and by inviting foreign investment. The vast majority of imported medicines come from neighbouring India. However, a number of Indian companies have in recent months been found to be in breach of regulations and subsequently denied importing rights, which will affect the level of imports. Headline Expenditure Projections ? Pharmaceuticals: LKR59.86bn (US$469mn) in 2012 to LKR67.77bn (US$524mn) in 2013; +13.2% in local currency terms and +11.8% in US dollar terms. ? Healthcare: LKR252.10bn (US$1.98bn) in 2012 to LKR281.89bn (US$2.18bn) in 2013; +11.8% in local cur ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment